Table A2.

Second-Line or Later Therapy by Initial Treatment Arm

Initial Treatment Arm	No. of Patients	Second-Line Therapy (%)
		None	Iri	Oxal	FU	Other
IFL	428	30	27	40	50	48
FOLFOX	691	18	64	22	51	56
IROX	380	25	34	20	54	51
Other	183	34	43	17	42	33
All	1,682	24	46	26	50	50

Abbreviations: Iri, irinotecan; Oxal, oxaliplatin; FU, fluorouracil; IFL, irinotecan plus bolus fluorouracil and leucovorin; FOLFOX, oxaliplatin, fluorouracil, and leucovorin; IROX, irinotecan and oxaliplatin.